A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
BeOne Medicines
BeOne Medicines
Debiopharm International SA
HRYZ Biotech Co.
NRG Oncology
Deciphera Pharmaceuticals, LLC
Gilead Sciences
Georgetown University
Rutgers, The State University of New Jersey
University of California, San Francisco
University of California, San Francisco
Seattle Children's Hospital
H. Lee Moffitt Cancer Center and Research Institute
Debiopharm International SA
National Cancer Institute (NCI)